Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Enhabit, Inc ( (EHAB) ) has shared an update.
On February 26, 2026, Enhabit, Inc. entered into an amended and restated credit agreement establishing a $315 million term loan A facility and a $160 million revolving credit facility, both maturing five years from closing. Interest is tied to SOFR or an alternate base rate with margins and commitment fees that vary based on the company’s total net leverage ratio, and the term loan amortizes at 7.50% per year starting June 30, 2026.
Proceeds are being used to refinance the company’s June 1, 2022 credit agreement, cover related fees, and support general corporate purposes, with the revolver also providing letter of credit capacity. The facilities are secured by first‑priority liens on substantially all assets, guaranteed by material domestic subsidiaries, and subject to customary covenants and financial maintenance tests on leverage and fixed charge coverage, underscoring lender protections and shaping Enhabit’s future capital flexibility.
The most recent analyst rating on (EHAB) stock is a Hold with a $13.80 price target. To see the full list of analyst forecasts on Enhabit, Inc stock, see the EHAB Stock Forecast page.
Spark’s Take on EHAB Stock
According to Spark, TipRanks’ AI Analyst, EHAB is a Neutral.
Enhabit, Inc’s overall stock score is driven by mixed financial performance, with profitability challenges offset by strong cash flow improvements. Technical indicators show positive momentum, while valuation remains a concern due to negative earnings. The earnings call and corporate events provide optimism with strategic growth initiatives and improved financial guidance, but potential regulatory risks remain.
To see Spark’s full report on EHAB stock, click here.
More about Enhabit, Inc
Enhabit, Inc. operates in the healthcare services industry, though this release focuses specifically on its corporate financing arrangements rather than its clinical operations or market focus. The company utilizes syndicated credit facilities to fund general corporate purposes and manage its capital structure in coordination with major commercial banks.
Average Trading Volume: 995,464
Technical Sentiment Signal: Buy
Current Market Cap: $688.8M
See more data about EHAB stock on TipRanks’ Stock Analysis page.